Given the multitude of suppressive mechanisms, it is remarkable that a relatively high proportion of patients can achieve objective tumor responses by blockade of a single pathway, such as PD-1/PD-L1 or CTLA-4. The gene discussed is CD274; the disease is neoplasm.